Renal Cell Carcinoma Clinical Trials 2022

Browse 100 Renal Cell Carcinoma Medical Studies Across 253 Cities

17 Phase 3 Trial · 1138 Renal Cell Carcinoma Clinics

Reviewed by Michael Gill, B. Sc.
25 Renal Cell Carcinoma Clinical Trials Near Me
Pittsburgh, PA
New York, NY
Houston, TX
Boston, MA
More Trial Locations
An interactive map to display trial locations for UPMC Department of Urology, Memorial Sloan Kettering Cancer Center, University of Texas MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(8), Massachusetts General Hospital, and 261 more locations.
Most Popular References for Renal Cell Carcinoma Clinical Trials
Frequency
Citation
Top Hospitals for Renal Cell Carcinoma Clinical Trials
Location
Active Renal Cell Carcinoma Clinical Trials
All Time Trials for Renal Cell Carcinoma
First Recorded Renal Cell Carcinoma Trial
Trials
Memorial Sloan Kettering Cancer Center, New York, New York
10
47
2003
MD Anderson Cancer Center, Houston, Texas
10
22
2003
Massachusetts General Hospital, Boston, Massachusetts
7
34
2007
Top Treatments for Renal Cell Carcinoma Clinical Trials
Top Cities for Renal Cell Carcinoma Clinical Trials
City
Active Renal Cell Carcinoma Clinical Trials
Top Active Site for Renal Cell Carcinoma Clinical Trials
Trial List
Houston, Texas
36
MD Anderson Cancer Center
How many renal cell carcinoma clinical trials are open to youth and / or seniors?
Most Recent Renal Cell Carcinoma Clinical Trials
Phase 3 Renal Cell Carcinoma Clinical Trials
Pediatric Renal Cell Carcinoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
6/24/2008
Phase 2
Senior Friendly Renal Cell Carcinoma Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Renal Cell Carcinoma
Treatment
Year
Mechanism of Action
Sponsor
Active Renal Cell Carcinoma Clinical Trials
Perflutren lipid microsphere
2020
Perflutren
UNC Lineberger Comprehensive Cancer Center
0
ARO-HIF2
2020
Arrowhead Pharmaceuticals
0
Retifanlimab
2019
Retifanlimab
Incyte Corporation
0
GEN-009 Adjuvanted Vaccine
2018
Genocea Biosciences, Inc.
0
Avelumab
2018
Avelumab
University of Utah
2
Isovue-M 200
2018
Iopamidol
Duke University
0
Nivolumab
2017
Nivolumab
Bristol-Myers Squibb
28

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 29th, 2021

Last Reviewed: August 15th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.